Evidence map›Paper›PMID 41754738›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Design, Docking, Synthesis, and Biological Evaluation of Pyrazolone Derivatives as Potential Dual-Action Antimicrobial and Antiepileptic Agents.

Yousef Al-Ebini, Manojmouli Chandramouli, Naga Prashant Koppuravuri, Thoppalada Yunus Pasha, Mohamed Rahamathulla, Salwa Eltawaty, Kamal Y Thajudeen, Mohammed Muqtader Ahmed, Thippeswamy Boreddy Shivanandappa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yousef Al-EbiniDepartment of Cosmetic Science, Faculty of Allied Medical Sciences, Al-Ahliyya Amman University, Amman 19328, Jordan.
Manojmouli ChandramouliDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B. G. Nagara 571448, Karnataka, India.ORCID 0000-0001-8850-7110
Naga Prashant KoppuravuriDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B. G. Nagara 571448, Karnataka, India.ORCID 0000-0003-3269-3094
Thoppalada Yunus PashaDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B. G. Nagara 571448, Karnataka, India.ORCID 0000-0003-0385-3343
Mohamed RahamathullaDepartment of Pharmaceutics, College of Pharmacy, King Khalid University, Abha 62223, Saudi Arabia.ORCID 0000-0001-8826-3718
Salwa EltawatyDepartment of Biomedical Science, Faculty of Pharmacy, Omar Al-Mukhtar University, Albayda P.O. Box 991, Libya.
Kamal Y ThajudeenDepartment of Pharmacognosy, College of Pharmacy, King Khalid University, Abha 61421, Saudi Arabia.ORCID 0000-0002-4064-8544
Mohammed Muqtader AhmedDepartment of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdul Aziz University, Al Kharj 11942, Saudi Arabia.
Thippeswamy Boreddy ShivanandappaDepartment of Biomedical Science, College of Pharmacy, Shaqra University, Al-Dawadmi Campus, Dawadmi 11961, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

1H NMRantiepilepticantimicrobialmass spectrometrymolecular dockingpyrazolone derivatives

Identifiers

PMID41754738
PMCPMC12943486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.